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ABSTRACT 
Flavonoids have been pointed as promisor compounds in the prevention of cognitive decline, 
characteristic of ageing and neurodegenerative diseases. Being synthetized by secondary 
metabolism of plants, flavonoids are present in a variety of foods and beverages of plant origin 
such as fruits, vegetables, tea, cocoa and wine. Epidemiological studies have associated the 
consumption of flavonoid rich foods with lower risk of cognitive decline. Some mechanisms of 
action of flavonoids had been already unveiled but several others remain to be explored. The 
present work aimed to test the modulatory effect of flavonoids on important transport systems 
at blood-brain barrier and neurons. Using in vivo supplementation this work intended to analyse 
flavonoids metabolic and cognitive effects and explore the potential of flavonoids as 
neuroinflammatory modulators. Also, this work intended to clarify if flavonoids were able to 
modulate microglia phenotype and consequent changes in synaptic plasticity.  
This thesis demonstrated the impact of flavonoids on glucose uptake at blood-brain barrier 
(BBB). The modulatory effects of flavonoids occurred in a structural dependent way. The flavan-
3-ols catechin and epicatechin did not have any effect on glucose uptake. However their 
methylated forms were able to increase this uptake. The effect of flavonols was in a different 
direction: both quercetin and miricetin decreased glucose uptake in a concentration-dependent 
manner. However, the glucuronic acid conjugated of quercetin, produced no effect on glucose 
uptake in BBB, supporting the role of metabolization on flavonoids effects. Moreover, at 
dopaminergic neurons, organic cations uptake, showed to be modulated by flavonoids and by its 
metabolites also in a structural dependent way. Flavan-3-ols inhibit [3H]-MPP+ uptake while 
naringenin, hesperitin, quercetin and metabolites increased this uptake. Flavonoids may be 
suggested as beneficial contributors in restoring homeostasis in dopamine disorders. Rodent 
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supplementation with an anthocyanin blackberry extract (BE) also showed influence of 
flavonoids in both dopaminergic and glucose systems. 
Wistar rats’ supplementation with a blackberry extract was also able to counteract some of 
neuroinflammatory effects induced by a high-fat diet. In vivo BE supplementation was also able 
to increase the expression of synaptic related proteins. Microglia phenotype has a role both in 
neuroinflammation and maintenance of neuronal synaptic homeostasis and seemed slightly 
affected by anthocyanins. Flavonoids interaction with communication microglia-neuron was also 
suggested by this work, as fractalkine expression appeared constantly altered by anthocyanins. 
This work presented some biological explanations which help to determine and understand the 
efficacy of flavonoids. Unrevealing new targets of flavonoids action may contribute to readdress 
future interventional studies.  
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RESUMO 
Os flavonoides têm sido apontados como compostos promissores na prevenção do declínio 
cognitivo, característico do envelhecimento e de doenças neurodegenerativas. Sendo 
sintetizados pelo metabolismo secundário das plantas, os flavonoides estão presentes numa 
enorme variedade de alimentos e bebidas de origem vegetal como hortofrutícolas, chá, cacau e 
vinho. Estudos epidemiológicos tem associado o consumo de alimentos ricos em flavonoides 
com um menor risco de declínio cognitivo. Alguns dos seus mecanismos de ação já foram 
descritos mas muitos outros permanecem ainda por explorar. O presente trabalho pretendeu 
testar os efeitos dos flavonoides na modulação de importantes sistemas de transporte ao nível 
da barreira hemo-encefálica e em neurónios. Recorrendo a modelos de suplementação in vivo, 
este trabalho analisou os efeitos metabólicos e cognitivos dos flavonoides e explorou o seu 
potencial como modulador da neuroinflamação. Este trabalho pretendeu ainda clarificar se os 
flavonoides teriam ação sobre o fenótipo da micróglia e consequentes alterações na plasticidade 
sináptica.  
Esta tese demonstrou o impacto dos flavonoides na captação de glicose pela barreira hemo-
encefálica (BHE). A capacidade de modular este transporte mostrou ser dependente da 
estrutura dos flavonoides. Os flavanóis catequina e epicatequina não tiveram efeito na captação 
de glicose. Contudo, as suas formas metiladas aumentaram esta captação. O efeito dos flavonóis 
ocorreu na direção oposta: tanto a quercetina como a miricetina diminuíram a captação de 
glicose de uma forma dependente da concentração. No entanto, o conjugado glicuronilado da 
quercetina não teve qualquer efeito, sustentando o papel da metabolização no efeito 
metabólico dos flavonoides. Também em neurónios dopaminérgicos, os flavonoides modulam 
um importante sistema de transporte, o da captação de catiões orgânicos, de forma dependente 
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da estrutura. Compostos pertencentes à classe dos flavanóis inibem a captação de [3H]-MPP+ 
enquanto que naringenina, hesperitina, quercetina e seus metabolitos aumentam esta captação. 
Deste modo, os flavonoides parecem ter um papel benéfico no restabelecimento da 
homeostasia em situações de desequilíbrio dopaminérgico. A suplementação em ratos Wistar 
com extrato de amora (EA) rico em antocianinas também demonstrou a influência dos 
flavonoides quer no metabolismo da dopamina como da glicose. 
A suplementação destes animais com um EA foi também capaz de prevenir alguns dos efeitos 
neuroinflamatórios induzidos pela dieta hiperlípidica e hipersacarídica. A suplementação com EA 
foi ainda capaz de induzir a expressão de proteínas relacionadas com a transmissão sináptica. O 
fenótipo da micróglia, que tem um papel importante quer na neuroinflamação quer na 
manutenção da homeostasia sináptica, foi ligeiramente afetado pela presença das antocianinas. 
A interação dos flavonoides com a comunicação entre a microglia e os neurónios foi também 
suportada por estes resultados em que a expressão da fractalkine aparece constantemente 
alterada pelas antocianinas. Este trabalho apresenta algumas explicações biológicas que ajudam 
a determinar e compreender a eficácia dos flavonoides. A compreensão e a revelação de novos 
alvos fisiológicos para a ação dos flavonoides pode redirecionar futuros estudos intervencionais. 
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INTRODUCTION 
“Let food be your medicine and medicine be your food” was a quote from Hippocrates 460-
370 B.C. who first raised the awareness of importance of diet in the maintenance and 
recuperation of health. The notion of diet specifically as brain function modulator is attracting 
interest by academics and non-academics that had recurred to herbal supplements and drugs as 
cognitive enhancers or as a way to delay cognitive decline (Maslen, Faulmuller et al. 2014, 
Muralidhara 2015). Besides pharmacological drugs, with known effects on brain function, the 
role of particular nutrients as coffee and glucose are also well-studied (Lieberman 2001, van der 
Zwaluw, van de Rest et al. 2015). Dietary fats is another subject of intense scrutiny where high-
fat -obesogenic- diets have been associated with long-term changes in neurotransmission and 
brain plasticity, resulting in cognitive dysfunction (Kanoski and Davidson 2011, Sullivan, Nousen 
et al. 2014). Moreover, adherence to a healthy diet patterns as Mediterranean diet results in 
better cognitive outcomes and a reduced risk for dementia (Solfrizzi and Panza 2014).  In support 
of these large population studies current bench studies are determining the pathways whereby 
individual elements of diet - as polyphenols, or specifically flavonoids- can influence brain 
function. 
Flavonoids, classes and chemical structure 
Flavonoids are polyphenolic compounds synthetized by secondary metabolism of plants. 
Their primordial roles in plants are protection, against UV radiation, pathogenic agents and 
predators, and attractiveness for pollination. These chemicals are not required for the 
immediate survival of the plant but increase its chance to survival. Their ecological roles in plant 
life and the molecular and biochemical similarities between plants biology and higher animals 
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may help to explain why these phytochemicals affect the human central nervous system (CNS) 
(Kennedy and Wightman 2011). Interaction with central and peripheral nervous systems can be 
a way of feeding dissuasion to potential herbivores, and in regard to this, these compounds 
evolved to act as neurotransmitters agonist or antagonists or neurotransmitter systems as well 
as forming structural analogous  of endogenous hormones (Kennedy and Wightman 2011). 
However the question of why and how flavonoids affect brain function is far from being 
answered. Its chemical structure can open some clues. 
Structurally, flavonoids are a subclass of polyphenols. The basic flavonoid structure is the 
flavan nucleus, which consists of a C6-C3-C6 structure constituted by two aromatic rings linked 
by a heterocyclic ring, labelled A, B and C (Figure 1). The various classes of flavonoids differ in 
the level of oxidation and pattern of substitution at the C ring, while individual compounds 
within a class differ in the arrangements of hydroxyl, methoxyl and glycosidic side groups (Table 
1) (Heim, Tagliaferro et al. 2002, Beecher 2003).   
  
Figure 1- Flavan nucleus structure. 
Until date more than 8000 flavonoids were already identified, and they can be classified into 
14 classes accordingly to their chemical structure. Six of these classes have received special 
attention by scientific community (See Figure 2): in particular (1) flavonols (e.g., kaempferol, 
quercetin), which are found in onions, leeks, and broccoli; (2) flavones (e.g., apigenin, luteolin), 
which are found in parsley and celery; (3) isoflavones (e.g., daidzein, genistein), which are mainly  
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found in soy and soy products; (4) flavanones (e.g., hesperetin, naringenin), which are mainly 
found in citrus fruit and tomatoes; (5) flavan-3-ols (e.g., (+)-catechin, (−)-epicatechin, 
epigallocatechin, epigallocatechin gallate (EGCG)), which are abundant in green tea, red wine, 
and chocolate; and (6) anthocyanidins (e.g., pelargonidin, cyanidin, malvidin), whose sources 
include red wine and berry fruits(Heim, Tagliaferro et al. 2002, Egert and Rimbach 2011, 
Williams and Spencer 2012). 
Flavonoids chemical structure make them natural free radical scavengers and from many 
years they were studied for their antioxidant properties (Rice-Evans, Miller et al. 1996). 
Contributing to this antioxidant nature are the presence of a B-ring catechol group capable of 
readily donating hydrogen and stabilize a radical specie (Rice-Evans, Miller et al. 1996). Other 
important structural features for antioxidant nature include the presence of 2,3 unsaturation in 
conjugation with a 4-oxo- function in the C-ring and the presence of functional groups capable of 
binding transition metal ions, such as iron and copper (Bors, Heller et al. 1990, Heim, Tagliaferro 
et al. 2002, Williams, Spencer et al. 2004) .  
However, as they cannot be regenerated as other antioxidants like ascorbic acid and α-
tocopherol  and because their concentrations are lower when compared with these molecules, 
other mechanisms arise to explain their biological effects (Williams, Spencer et al. 2004). These 
mechanisms can involve interaction with several receptors and signaling cascades, mainly 
Pi3K/Akt and MAP Kinase pathways that lead to regulation of transcription factors and gene 
expression. This includes several genes related to enzymatic activity, as those involved in 
biotransformation and antioxidant activity. Flavonoids have also the ability to regulate several 
transport systems or substrates at different membrane levels. They can also modulate 
expression of genes involved in cell cycle regulation, cell proliferation, angiogenesis, 
inflammation and even in cognitive function. Also they are known to induce beneficial effects on 
cardiovascular system affecting both peripheral and cerebral blood flow (Youdim, Spencer et al. 
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2002, Vauzour, Vafeiadou et al. 2008, Martel, Monteiro et al. 2010, Visioli, De La Lastra et al. 
2011, Williams and Spencer 2012) 
 
Table 1- Major classes of flavonoids: examples, chemical structure, and main dietary sources. 
Adapted from Negrão et al, 2009 (Negrão and Faria 2009). 
Class of flavonoids  Molecular Structure Functional groups and examples Food sources 
Flavonols 
 
R1=H; R2=OH; R3=H: kaempferol 
R1=OH; R2=OH; R3=H:quercetin 
R1=OH; R2=OH; R3=OH: myricetin 
Onions, apples, curly kale, leek 
Flavan-3-ols 
 
R1=H; R2=OH; R3=H: (+)-catechin 
R1=OH; R2=H; R3=H: (-)-epicatechin 
R1=OH; R2=OH; R3=OH: (+)-gallocatechin 
Chocolate, green tea, beans, cherry, grape seeds, red wine 
Flavones 
 
R1=H; R2=OH: apigenin 
R1=OH; R2=OH:luteolin 
Parsley, celery, capsicum pepper 
Flavanones 
 
R1=H; R2=H; R3=OH: naringenin 
R1=OH; R2=OH; R3=OMe: hesperetin 
Orange juice, grapefuit juice, lemon juice 
Isoflavones 
 
R1=H: daidzein 
R2=OH: genistein 
Soy flour, soy beans, soymilk 
Anthocyanidins 
 
R1=H; R2=H: pelargonidin 
R1=OH; R2=H: cyanidin 
R1=OH; R2=OH: delphinidin 
R1=OMe; R2=OH: petunidin 
R1=OMe; R2=OMe: malvidin 
Aubergine, blackberry, blackcurrant, blueberry 
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Flavonoids intake 
Polyphenols are widespread, virtually present in all foods and beverages of plant origin, such 
as fruits, vegetables, tea, cocoa and wine. It is estimated that two thirds of total polyphenols 
ingested are flavonoids. However, for several reasons, it is extremely difficult to estimate the 
daily average intake of flavonoids, such as the extensive diversity of chemical structures that 
makes the estimation of flavonoid content in foods complex, the analytical method used for 
these estimations, variation of content with geographical region, harvesting and season, as well 
as dietary habits of people. Few estimations of dietary intake are available and the attained 
values are somehow different. Scalbert and Williamson have already proposed that the total 
dietary intake of polyphenols is about 1 g/day (Scalbert and Williamson 2000). 
Recently, combined data from European Food Safety Authority (EFSA) and FLAVIOLA – 
Flavonol Food composition database which contains food composition data for approximately 
3,000 food items was compiled to estimate the flavonoid intake in European countries. Mean 
intake of total flavonoids in Europe was found to be around 428 mg/day.  Mean intake of most 
flavonoids in Europe is broadly comparable with intake in Australia or with observational studies 
conducted in the US and Europe (Vogiatzoglou, Mulligan et al. 2015). However, mean intake of 
anthocyanidins in some countries (Finland, Latvia and France) was similar or higher (19 mg/day) 
than intake in Nurses Health Study II (10.9 mg/day), or in the UK twin study (17.8 mg/day) where 
high anthocyanidins intake was associated with a reduced risk of myocardial infarction or 
vascular function respectively (Jennings, Welch et al. 2012, Cassidy, Mukamal et al. 2013). 
Biokinetic of flavonoids  
Absorption and distribution and biotransformation 
For several years flavonoids bioavailability was considered low. With exception of flavan-3-ols 
subclasse, flavonoids in nature are mainly glycosides (Aherne and O'Brien 2002). Glycosides have 
considerable size and planar structure with low lipophilicity which turns its absorption difficult 
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(Walle 2004). Although intact anthocyanin glycosides have been detected in circulation, most 
glycated flavonoids are hydrolysed to their aglicon form by intestinal enzymes prior to 
absorption (Nurmi, Mursu et al. 2009). Two enzymes are involved in this deglycosylation 
process: lactase phloridzin hydrolase (LPH) and cytosolic β-glucosidase (CBG). The first is present 
in the luminal side of enterocytes and aglicones resultants from their action are able to easily 
cross the membrane or undergo further biotransformation by colonic microbiota. CBG is present 
inside the enterocyte, which implies the need of the flavonoid to cross apical cell membrane 
(Day, Canada et al. 2000, Nemeth, Plumb et al. 2003). Glucose transporters have been proposed 
as implicated in this process (Faria, Pestana et al. 2009). The need for deglicosylation, active 
transport into the cells or the limited absorption ability of colon limits the amount of flavonoids 
expected to be found in plasma. 
 In fact, some intervencional studies have shown great variability in flavonoids bioavailability 
(Williamson and Manach 2005). Several factors can influence this bioavailability: the presence of 
fiber, macro- and micronutrients, gastrointestinal transit time, and gut microbiota. Notably, the 
food matrix can also impact the degree of flavonoid bioaccessibility; also proanthocyanidins and 
other flavonoid polymers must be broken down into monomeric or dimeric units before they can 
be absorbed (Manach, Scalbert et al. 2004, Manach, Williamson et al. 2005). Flavonoids 
absorption has been discussed as occurring in further places other than at intestinal level. 
Anthocyanins have been shown to be absorbed at gastric level and absorption at oral cavity has 
also been proposed (Faria, Fernandes et al. 2014). Furthermore, flavonoids can undergo further 
metabolization by colon microbiota and this colonic metabolites may also be absorbed and 
consequently be implicated in biological activity (Faria, Fernandes et al. 2014). 
Flavonoids undergo extensive conjugation by Phase II enzymes producing methoxylated, 
glucuronidated, and sulphated compounds during and after absorption process. The plasma 
concentration of unconjugated flavonoid is usually very low, implying an extensive conjugation 
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of the absorbed flavonoid. The extent of this biotransformation suggests that either metabolites, 
the parent glucoside or free form of the compound can be responsible for flavonoid bioactivity 
(Corcoran, McKay et al. 2012). This issue will be taken in account in the next chapters.  
Flavonoids access to the brain 
To exert activity, flavonoids do not necessarily need to reach the brain. They can have 
biological function even without being absorbed at intestinal level, by changing gut microbiota 
or inducing local stimulus that may act at brain level (Foster and McVey Neufeld 2013, Faria, 
Fernandes et al. 2014). Notwithstanding, flavonoids can have direct action on nervous system 
and this will, in part, depend on the extension of their accessibility to the brain. As presented 
above flavonoids are indeed bioavailable at intestinal level and reach the plasmatic circulation 
where they can find another barrier before reach the brain. This blood-brain barrier (BBB) is a 
restraining barrier of brain capillary endothelial cells tightly connected, limiting the access to 
most small polar molecules and macromolecules to the brain (Abbott, Patabendige et al. 2010). 
Besides fulfilling a protective role by severely limiting the movement of substances into the 
brain, BBB has also the crucial role of supplying essential nutrients, hormones, drugs or 
xenobiotics to the brain (Palmer 2010). Specific transport systems therefore are expressed in the 
BBB to ensure an adequate supply of these substances. Literature about flavonoids ability to 
interact with nutrient supply at this level was scarce or inexistent. 
Besides the potential to interact locally at BBB, permeability of BBB to flavonoids has been 
already demonstrated in several models. Most of the flavonoids and respective metabolites 
tested are able to cross the different models of BBB (Youdim, Dobbie et al. 2003, Faria, Pestana 
et al. 2010, Faria, Meireles et al. 2014, Yang, Bai et al. 2014). In agreement, several animal 
studies have detected some flavonoids and metabolites on brain tissue. For example, 
epicatechin glucuronide and 3’-O-methyl epicatechin glucuronide have been found in the brain 
of rats after oral supplementation with epicatechin for 1, 5 or 10 days (Abd El Mohsen, Kuhnle et 
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al. 2002). Similar observations have been made for the flavonones: naringenin and  hesperetin, 
which  have  been  detected  in  brain  tissue  after intravenous administration (Tsai and Chen 
2000, Lin, Hou et al. 2014) and for EGCG (Suganuma, Okabe et al. 1998) and anthocyanins 
(Talavéra, Felgines et al. 2005, El Mohsen, Marks et al. 2006) after oral ingestion. Recently, a 
dose-dependent accumulation of several flavonoids was seen in cerebellum and frontal cortex in 
weanling pigs (Chen, Kritchevsky et al. 2015). Curiously there is also evidence of flavonoids brain 
accumulation after long-term exposure (Ferruzzi, Lobo et al. 2009), which may contribute to 
increase its bioactive potential.  
Evidence from protective role of flavonoids 
The association of fruits and vegetables consumption with lower risk of development of 
cardiovascular diseases has been strongly supported by epidemiological data as reviewed by 
Wang et al  (Wang, Ouyang et al. 2014). Also, several studies have reported an association of 
increased intake of vegetables with a lower risk of dementia and slower rates of cognitive 
decline in older age (Loef and Walach 2012). Flavonoids may be in part responsible for some of 
these protector effects (Hooper, Kroon et al. 2008). Indeed some epidemiological studies have 
suggested that flavonoids play a protective role against cognitive decline and Alzheimer disease 
(Engelhart, Geerlings et al. 2002). The PAQUID Study was one of the first epidemiological studies 
to demonstrate such associations (Commenges, Scotet et al. 2000, Letenneur, Proust-Lima et al. 
2007, Schaffer, Asseburg et al. 2012). Recently Kesse-Guyot and colleagues showed an 
association between polyphenols intake and better performance in language and verbal memory 
tasks (Kesse-Guyot, Fezeu et al. 2012). Also a positive association between flavonoids intake and 
prevention of Parkinson’s disease has been found (Gao, Cassidy et al. 2012) expanding the 
spectrum of favorable effects of their consumption. 
Furthermore, some evidences from interventional studies are also available: elderly adults 
consuming blueberry juice showed some neurocognitive benefits through memory improvement 
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(Krikorian, Shidler et al. 2010) and supplementation with concord juice enhanced cognitive 
function in elderly adults with early memory decline (Krikorian, Nash et al. 2010). Also global 
cognitive function was significantly better after 8-wk consumption of flavanone-rich juice than 
after 8-wk consumption of the low-flavanone control (Kean, Lamport et al. 2015). 
Epidemiological studies gave rise to many investigations using animal models. Some studies 
have demonstrated, for instance, that supplementation with berry extracts with high levels of 
anthocyanins or other polyphenols can reverse brain insult and age-related cognitive 
decrements in rodents (Willis, Shukitt-Hale et al. 2009). Supplementation with these extracts 
resulted in improved memory, inducing better performance at Morris water maze and object 
recognition (Joseph, Shukitt-Hale et al. 2009, Shukitt-Hale, Cheng et al. 2009, Rendeiro, Vauzour 
et al. 2012). 
 Flavonoids have also been presented as neuroinflammation modulators (Spencer, Vafeiadou 
et al. 2012). Neuroinflammation was classically seen as a result of microglia activation cause or 
consequence of neuronal death, which is a common final event in neurodegenerative diseases 
(Rodrigues, Sanberg et al. 2014). This neuroinflammation contributes to the neurodegenerative 
cascade leading to neurodegenerative pathologies as Alzheimer disease, Parkinson’s disease and 
clinical dementia (Hirsch and Hunot 2009, Gorelick 2010). Flavonoid interventions that aimed to 
target this feature have received particular interest and promising results as reviewed by Jang et 
al (Jang and Johnson 2010) . 
 Previous literature show that flavonoids action involves in part decreases in 
oxidative/inflammatory stress signaling and also that hormetic effects may be involved in 
protective mechanisms of neurons against oxidative and inflammatory stressors. Nevertheless, 
many of the mechanisms underpinning their beneficial effects remain to be elucidated (Spencer 
2009, Vauzour 2012), and this thesis intended to provide further insights into this field.  
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AIM 
 
This study aimed to explore the potential of specific food components, the flavonoids, on 
brain health, hypothesising that they would represent a positive approach to maintain brain 
homeostasis and function.  
In order to accomplish that, several specific goals were defined:  
 Test the effect of flavonoids on modulation of glucose  uptake at blood-brain barrier 
level; 
 Determine whether flavonoids were able to modulate important transport systems in 
neurons; 
 Analyse flavonoids metabolic and cognitive effects after in vivo supplementation, in a 
context of standard and high-fat diet; 
 Explore the potential of flavonoids as neuroinflammatory modulators; 
 Determine whether flavonoids were able to change microglia phenotype and 
consequently change synaptic plasticity. 
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Anthocyanin effects on microglia M1/M2 phenotype: consequence on neuronal differentiation and fractalkine expression 
Manuela Meireles1, Cláudia Marques1, Sónia Norberto1,2, Paulo Santos3, Iva Fernandes4, Nuno Mateus4, Ana Faria1,4,5, Conceição Calhau1,2* 
1- Department of Biochemistry, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal 2-CINTESIS - Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal 3- Life Sciences Department, University of Coimbra, 3001-401 Coimbra, Portugal 4-REQUIMTE/LAQV, Faculty of Sciences, University of Porto, 4169-009 Porto, Portugal 5-Faculty of Nutrition and Food Sciences, University of Porto, 4200-465 Porto, Portugal  
Abstract 
Microglia mediate multiple aspects of neuroinflammation, including cytotoxicity, repair, regeneration, and immunosuppression due to their ability to acquire diverse activation states, or phenotypes. Modulation of microglial phenotype or microglia-neuron crosstalk can be an appealing neurotherapeutic strategy. Anthocyanins are a class of flavonoids found e.g. in berries that has been attracting interest due to its neuroprotective potential. N9 microglia cell line was treated with 1 µM cyanidin (Cy), cyanidin-3-glucose (Cy3glc) and a methylated form of cyanidin-3-glucose (Met-Cy3glc) in basal conditions and with LPS/IL-4 stimulation. SH-SY5Y cell line was treated with the conditioned medium of microglia and with the anthocyanins alone. At basal conditions, treatment with anthocyanins for 24 h induced a less pro-inflammatory profile. Decreased TNF-α mRNA expression was induced either by Cy and Met-Cy3glc. LPS markedly increase IL-6 mRNA expression, which was lowered by Cy3glc. IL-1β LPS-induced expression was reverted by Cy. Cy increased CX3CL1 mRNA expression in SH-SY5Y comparing either with control or LPS. Anthocyanins and metabolites were not able to shift microglia to an M2 strict phenotype however they did interact with microglia biology. There was an attenuation of M1 phenotype and increase of neuronal expression of CX3CL1. Understanding how flavonoids interact with microglia-neuron crosstalk can open new directions for future flavonoids interventions.  
*Corresponding author: Conceição Calhau Department of Biochemistry  Faculty of Medicine of the University of Porto Al. Prof. Hernâni Monteiro 4200-319 Porto – Portugal Email: ccalhau@med.up.pt  Phone/Fax: +351 22 551 36 24  1-Introduction In the last years there has been a growing interest on the role that microglia plays within the brain. Microglia were well described as the immune effector cells crucial in response to injury in central nervous system (CNS), generating and maintaining inflammatory responses (1). Localized inflammation in CNS has been proved important in the initiation and progress of many neurodegenerative diseases. Still, the relevance of investigating microglia is no longer restricted to neuroinflammation and neurodegenerative diseases (2). Knowledge that 
microglia are able of acquiring diverse phenotypes in response to environmental stimulus is shifting the perspective of microglia role in the brain (3). Similar to what was previous described for macrophages in periphery, microglia phenotype may be determinant in their functions (4). Microglia phenotype is still a matter of debate, however four activation states have been proposed: the classical M1 activated state; M2a, an alternative activation state involved in repair and regeneration; M2b, an immunoregulatory phenotype and M2c, an acquired deactivating phenotype (5). M1 classical activation is induced by microbial compounds (LPS) or pro-inflammatory cytokines such as interferon-γ (IFN-γ). TNF-α, IL1-β, IL-6, iNOS are typical hallmarks of this classic M1 phenotype. In contrast, IL-4 and IL-10 have shown to differentiate microglia towards an M2a and M2c phenotype respectively, while M2b phenotype is triggered by immune complexes. Arginase I, the 
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chitinase-like 3 (YM1), FIZZ 1, CCR2 are common molecular markers of M2 alternative activation. The impact of switching in neuronal function is still not completely unveiled, but an M2 phenotype is more likely to be related with synaptic pruning and synaptic plasticity, functions recently attributed to microglia (6, 7). One way neurons and microglia use to communicate is by ligand-receptor axis as CX3CL1/CX3CR1. CX3CL1, also known as fractalkine, is expressed in neuronal cells, binds to and activates CX3CR1 receptors on microglia (8, 9). Modulation of microglial phenotype or microglia-neuron crosstalk could be an appealing neurotherapeutic strategy. Flavonoids are a class of polyphenols found in fruits and vegetables. In the last decade epidemiological studies have shown the ability of flavonoids to prevent the decline of cognitive function characteristic of ageing and also to improve several memory dependent tasks (10, 11). Several possible mechanisms are pointed for flavonoids action, such as antioxidant potential, ability to interact with signalling cascades, induce vascularization, modulation of nutrients or neurotransmitter transport and ability to counteract neuroinflammation (12-15). Flavonoids have been pointed as inhibitors of microglia activation and counteract release of some pro-inflammatory cytokines as TNF-α and IL-1β (16). However as the concept of microglia and its function is changing, expanding this knowledge is compulsory. If flavonoids are, in fact, able to keep microglia in a senescent state as previously suggested, the question is if they would also induce a M2 prone state (17-19).  Future therapeutic approaches targeting cerebral inflammation may shift from suppress of all microglia activation to subtly modify the balance between different phenotypes [19]. In this work we aimed to analyse whether flavonoid treatment could affect microglia M1 or M2 phenotype.  Also, as microglia has been implicated in modulation of synaptic structures, the effect on differentiation or expression of synaptic-related molecules in neurons will be evaluated.  2-Methods 2.1- Cell cultures As model for microglia, studies were performed with the microglia cell line N9. This cell line (firstly developed by Righi M 1995) was kindly provided by Claudia Verderio, from National Research Council, Milan, Italy. Cells were grown in RPMI 1640 medium (Sigma-Aldrich Chemicals®,Madrid, Spain) containing 5% fetal 
bovine serum, 25 mM glucose, 100 μg/ml streptomycin and 0.25 μg/ml amphotericin B (all from Sigma) and passaged twice a week. Cell lines were maintained in a humidified atmosphere of 5% CO2–95% air at 37°C. The neuroblastoma cell line SH-SY5Y, used as undiffentiated neuron model, was grown in Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham (DMEM-F12Ham, Sigma-Aldrich Chemicals®,Madrid, Spain), supplemented with 1.19 g/L NaHCO3, 3.47 g/L HEPES, 5% fetal bovine serum, 100 μg/mL streptomycin and 0.25 μg/mL amphotericin B (all from Sigma). Culture medium was changed every 2–3 days and the culture was split every 7 days.   2.2- Treatment conditions and microglia stimulation Microglia cells were seeded at a density of 3x104 cells per well in six-well plates. After 24 hours cells were treated: (i) with either 1 µM cyanidin (Cy), cyanidin-3-glucose (Cy3glc), a mixture of 3’-methyl-cyanidin and 4’-methyl-cyanidin (Met-cy3glc) or vehicle alone for more 24 hours (figure 1A); (ii) with lipopolysaccharide (LPS from Escherichia coli 011:B4, L4391, Sigma-Aldrich Chemicals®,Madrid, Spain) or IL-4 mouse recombinant (Prepotech, London, UK) and simultaneously with either 1 µM cy, cy3gl, met-cy3glc or vehicle alone for more 24 hours (figure 1B).   Figure 1- Schematic representation of the experimental setups  
  SH-SY5Y was treated with microglia conditioned medium (CM) of the several conditions described in (ii). Also, SH-SY5Y were cultured 
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with conditioned medium of LPS activated microglia and simultaneously treated with cy, cy3gl, met-cy3glc or vehicle alone (figure 1C ). For studies involving CM, medium was collected from the microglia after activation, centrifuged 350 g for 5 minutes and the supernatant (1.5 ml) was used (20). SH-SY5Y medium was replaced for CM for 24 hours.    2.3- RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA from treated cells was isolated using RNA-STAT 60 reagent (AMS Biotechnology, UK) according with manufacturer's instructions. Purity of RNA samples was confirmed by absorbance ratio 260/280 nm higher than 1.8. RNA samples were treated with DNaseI (RQ1 RNase-free DNase, Promega, Portugal). cDNA was synthetized from 1 µg of treated mRNA with  NZY First-Strand cDNA Synthesis Kit (NZYTech, Portugal). Quantitative real-time polymerase chain reaction (qRT-PCR) was run on Lightcycler®96 (Roche Diagnostics, USA). Ten microliter reactions were set on 96 well plates using 0.2 μM of each primer and 5 μL of FastStart Essential DNA Green Master (Roche Diagnostics, USA). Cycling conditions were as follows: denaturation (95°C for 10 min), amplification and quantification (95°C for 10 s, annealing temperature (AT- see table 1) for 10 s, and 72°C for 10 s, with a single fluorescence measurement at the end of the 72°C for 10 s segment) repeated for 55 cycles, and a final melting 95°C 10 sec, 65°C 60 sec and 97°C for 1 sec. The specific primers sequence used are described on table 1. Data were analysed using LightCycler® 96 SW analysis Software v1.1. Results obtained were normalized for two housekeeping genes (hypoxanthine-guanine-
phosphoribosyltransferase- HPRT- and cytochrome c1- Cyc1- for N9 cells; HPRT and eukaryotic translation initiation factor 4A2 for SH-SY5Y cells ) by the 2-ΔΔCt method (20-22).   2.4- Differentiation studies SH-SY5Y cells were seeded at a density of 2 x 105 cells/well in a six-well plate and cultured for 24 hours. The medium was then replaced with the CM of microglia for more 24 hours. Digital images of five randomly selected fields were acquired with an optical microscope (Nikon Eclipse 50i®, Melville, USA), at a magnification of 20x. Cells bearing neurite-like processes longer than the diameter of the cell body were counted. Following previous literature (23) the percentage of differentiation was calculated from the number of cells that showed process outgrowth divided by the total number of cells in each field.   2.5-Statistical analyses   Values are expressed as the arithmetic mean (SEM) of duplicated samples from four independent experiments. Statistical significance of the difference between various groups was evaluated with GrahPad Prism® 6.0 Software by one-way analysis of variance (ANOVA) followed by Fisher’s LSD multiple comparison test. Differences were considered significant when p <0.05.  3-Results 3.1- Effect of cyanidin-3-glucose and derivatives on microglia basal phenotype The first goal of this work was to measure the anthocyanin direct effects on microglia polarization. N9 microglia cells were treated with cyanidin (Cy), cyanidin-3-glucose (Cy3glc) 
Table 1- Sequence of primers used and respective annealing temperature 
N9 Forward  Reverse  T (ºC) 
HPRT1 5´ TGCTGACCTGCTGGATTACA 3’ 5’ TTTATGTCCCCTGTTGACTGG 3’ 59 
TNF-α 5’ GATCGGTCCCCAAAGGGATG 3’ 5’ TGAGGGTCTGGGCCATAGAA 3’ 63 
IL-6 5’ GTTCTCTGGGAAATCGTGGA 3’ 5’ TTCTGCAAGTGCATCATCGT 3’ 59 
iNOS 5’ GACGAGACGGATAGGCAGAG 3’ 5’ GTGGGGTTGTTGCTGAACTT3’ 59 
Arg1 5’ AAAGCTGGTCTGCTGGAAAA 3’ 5’ ACAGACCGTGGGTTCTTCAC 3’ 59 
Ym1 5’ CAGTGGCTCAAGGACAACAA 3’ 5’ TCTCTGGTGACAGAAAGAACCA 3’ 59 
CCR2 5’ CTCAGTTCATCCACGGCATAC 3’ 5’ GACAAGGCTCACCATCATCG 3’ 60 
Cyc1 5’ TCAACCCTTACTTTCCCGGC 3’ 5’ CCCATGCGTTTTCGATGGTC 3’ 63 
CX3CR1 5´ CTTTGGGGGCATATTCTTCA 3’ 5’ ACGCCCAGACTAATGGTGAC 3’ 59 
SH-SY5Y   
CX3CL1 5’ CACCACGGTGTGACGAAATG 3’ 5’ TCTCCAAGATGATTGCGCGT 3’ 63 
Eif4a2 5’ CGGTTTTGAGAAGCCTTCCG 3’ 5’ GCCAGTACCTGACTGAGCTT 3’  60 
Synapsin 5’ AAATATGACGTGCGTGTCCA 3’ 5’ TGGTCTTCCAGTTCCCTGAC 3’  59 
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and a mixture of 3’ and 4’-methylcyanidin-3-glucose (Met-cy3glc) for 24 hours. mRNA expression of IL-6, iNOS, TNF-α (specific markers of M1), Ym1, CCR2 and Arg1 (specific markers of M2) and CX3CR1 also associated with M2 were analysed. TNF-α mRNA expression was consistently lowered by all the conditions tested although for Cy3glc without statistical significance (Table 2).    Table 2- Effect of 1 μM of cyanidin (Cy), cyanidin-3-glucose (Cy3glc), 3’ and 4’-Met-Cy3glc (Met-Cy3glc), on the transcription of microglia markers in N9 microglia cell line.  Basal   
 Cy Cy3glc Met-Cy3glc 
IL-6 1.15 (0.52) 0.80 (0.35) 0.71 (0.32) 
iNOS 2.52 (0.79) 2.57 (1.15) 1.45 (0.52) 
TNF-α 0.79 (0.05)* 0.78 (0.13) 0.71 (0.07)* 
IL-1β 1.02 (0.11) 0.97 (0.16) 0.84 (0.14) 
Ym-1 2.80 (1.2) 1.52 (0.87) 2.09 (1.03) 
CCR2 ND ND ND 
Arg-1 ND ND ND 
CX3CR1 0.79 (0.42) 1.19 (0.53) 0.95 (0.47) 
Results obtained were normalized for two housekeeping genes HPRT and cytochrome c1 by the 2-ΔΔCt method and expressed as mean (SEM). Statistical significance was assessed by one way ANOVA followed by Fisher’s LSD multiple comparison test. *p<0.05  
CCR2 and Arg1 expression was under detection levels and there were no significant differences in the expression of other tested markers.  3.2- Effect of cyanidin-3-glucose and derivatives under microglia LPS-stimulation In order to induce a pro-inflammatory (M1) phenotype N9 microglia were stimulated with LPS. LPS markedly increase IL-6 and IL-1β expression, which as previously been associated with LPS stimulation (5). iNOS and TNF-α expression were not significantly changed by LPS induction (Table 3). The effect of the compounds was tested only on the M1 and M2 parameters significantly changed by LPS. Cy3glc treatment prevented LPS induced IL-6 increase. Curiously, Cy also prevented the IL-1β LPS-induced expression.  CX3CR1 was not significantly affected by any of the tested conditions (Table 3).  3.3- Effect of cyanidin-3-glucose and derivatives on microglia under IL-4 stimulation To understand if anthocyanins could potentiate the IL-4 induction to M2 phenotype, microglia cells were treated with IL-4 for 24 hours in the presence or absence of flavonoids. None of the tested parameters were significantly changed by IL-4 treatment. Stimulation with IL-4 curiously decreased CX3CR1, and this effect was independent of the presence of the compounds (Table 3). 
Table 3- Effect of 1 μM of cyanidin (Cy), cyanidin-3-glucose (Cy3glc), 3’ and 4’-Met-Cy3glc (Met-Cy3glc), on the transcription of microglia markers in induced N9 microglia cell line 
Results obtained were normalized for two housekeeping genes HPRT and cytochrome c1 by the 2-ΔΔCt method and expressed as 
mean (SEM). Statistical significance was assessed by one way ANOVA followed by Fisher’s LSD multiple comparison test. *p<0.05 vs 
control; #p<0.05 vs LPS 
 LPS     IL4    
 - Cy Cy3glc Met-Cy3glc  - Cy Cy3glc Met-Cy3glc 
IL-6 81.85 (21.2)* 59.1 (12.47)* 37.50 (15.70)# 79.31 (15.04)*  0.66 (0.29) - - - 
iNOS 98.28 (52.24) - - -  1.23 (0.09) - - - 
TNF-α 3.07 (0.93) - - -  0.35 (0.15) - - - 
IL-1β 48.56 (15.13)* 40.69 (10.19) 55.43 (18.62)* 73.93 (20.81)*  0.40 (0.27) - - - 
Ym-1 ND - - -  ND - - - 
CCR2 ND - - -  ND - - - 
Arg-1 ND - - -  ND - - - 
CX3CR1 0.78 (0.49) 0.65 (0.41) 2.85 (2.3) 1.10 (0.71)  0.15 (0.02)* 0.16 (0.02)* 0.20 (0.02)* 0.07 (0.03)* 
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Table 4- Effect of microglia conditioned medium stimulated in the presence/absence of 1 μM of cyanidin (Cy), 
cyanidin-3-glucose (Cy3glc), 3’ and 4’-Met-Cy3glc (Met-Cy3glc), on the neuronal transcription of CX3CL1 and synapsin. 
SH-SY5Y  LPS     IL4    
 - Cy Cy3glc Met-Cy3glc  - Cy Cy3glc Met-Cy3glc 
CX3CL1 1.15 (0.36) 2.30 (0.44)*# 0.76 (0.1) 0.93 (0.24)  1.28 (0.36) 1.23 (0.27) 0.79 (0.28) 1.23 (0.30) 
Synapsin 3.81 (1.96) 3.32 (1.69) 2.74 (1.53) 1.11 (1.10)  1.04 (0.35) 0.77 (0.11) 1.02 (0.32) 0.91 (0.17) 
Results obtained were normalized for two housekeeping genes HPRT and Eif4a2 by the 2-ΔΔCt method and expressed as mean (SEM). Statistical significance was assessed by one way ANOVA followed by Fisher’s LSD multiple comparison test. *p<0.05 vs control; #p<0.05 vs LPS 
 
  Figure 2- Effect of 1 μM of cyanidin (Cy), cyanidin-3-glucose (Cy3glc), 3’ and 4’-Met-Cy3glc (Met-Cy3glc) on differentiation of neuronal cells SH-SY5Y. Cells bearing neurite-like processes longer than the diameter of the cell body were counted five randomly selected fields. The percentage of differentiation was calculated from the number of cells that showed process outgrowth divided by the total number of cells in each field. Results are expressed as percentage of control (mean ± SEM). 
 3.4- Neuronal response to conditioned medium of microglia stimulated with LPS or IL-4 in the presence/absence of flavonoids  The SH-SY5Y cell line was treated with the conditioned medium of the above conditions (Fig. 1B). As shown in table 4, LPS does not alter the CX3CL1 mRNA expression. Cyanidin did increase this expression comparing either with control and LPS. Results from neuronal differentiation may suggest an influence by Cy3glc and derivatives. (Fig. 2). CX3CL1 was not affected by IL-4 treatment either in the presence or absence of flavonoids (Table 4). Synapsin is a common neurotransmitter vesicular marker, used as an indicator of neurotransmission. In this study, synapsin expression was not significantly altered (table 4). 
The direct effect of flavonoids in neuronal response to LPS activated conditioned microglia was also tested (Fig 1C). The results represented on Figure 3 confirmed the increase in fractalkine expression induced by cyanidin, simulating the effect obtained with the conditioned media (Table 4). 
 Figure 3 – Effect of 1 μM of cyanidin (Cy), cyanidin-3-glucose (Cy3glc), 3’ and 4’-Met-Cy3glc (Met-Cy3glc) on the transcription of CX3CL1, in neuronal cells treated with conditioned medium (CM) from LPS-stimulated microglia. Results obtained were normalized for two housekeeping genes HPRT and Eif4a2 by the 2-ΔΔCt method and expressed as mean ± SEM. Statistical significance was assessed by one way ANOVA followed by Fisher’s LSD multiple comparison test. *p<0.05 vs CM or CM LPS  4- Discussion So far, the few studies using flavonoids tested them in order to examine changes in microglia “activation” (17). Nowadays it is known that besides failing to represent the non-pathological, normal functions of microglia, the term “activation” is vague and provides no specific information about the many possible  microglial phenotypes (18). Previous work from our group has shown that in vivo supplementation with a blackberry anthocyanin extract induced some changes in synaptic related proteins (15). As microglia has been 
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implicated in synaptic pruning (24) it was hypothesized that flavonoids would have an impact in neuron function by changing microglia phenotype. Despite the inherent limitations of in vitro experiments, minimizing surrounding variables has the advantage of better understanding of direct causal effects (25). In this study the use of conditioned medium added a dynamic view of the overall process. Although not comprising physical interaction between the two cell types, this model allows the study of direct neuronal consequence of microglia released molecules, present on conditioned medium (23, 26).  The retroviral immortalized microglia N9 cell line is generally considered a reliable in vitro model which enables the study of microglial function in the absence of contaminant cells which are present in primary cultures (27). Anthocyanins tested in this work were able to generally induce a less pro-inflammatory profile of N9 cells. Decreased TNF-α expression was induced either by cyanidin and methylated form of cyanidin-3-glucose. These microglia cells were described as able to polarize in response to different stimulus (28). In the present study, LPS significantly increased IL-6 and IL-1β and seemed to increase iNOS and TNF-α. Liu et al 2012 (28) previously suggested that LPS induced polarization was irreversible. However, in this model, we tested the anthocyanins and LPS simultaneously expecting that this would hinder  the changes induced by stimulation. This was supported by the decrease in IL-6 expression by Cy3glc. The anthocyanin on its native form was able to counteract the increase induced by LPS of IL-1β and also had a mild effect on IL-6 decrease. IL-1β is classically associated with inflammation, and LPS was able to induce an increase in IL-1β mRNA expression. Previous results of animal supplementation with blackberry extract rich in anthocyanins, has also shown an increase in IL-1β release simultaneously to increase in synaptic plasticity related molecules (15). Although classically associated with inflammatory profile, the role of this cytokine may not be completely unveiled since recent studies have suggested a role in neurogenesis and neuronal differentiation (29, 30).  Cy3glc and derivates counteracted LPS-induced inflammation to a lesser extent than shown to malvidin, another anthocyanidin, in a previous study (31). However the doses used in the present study were lower and probably more realistic. Anthocyanins were used at 1 μM, concentration that reflects reachable plasmatic 
concentrations (32). Not discarding the possibility that chronic consumption of anthocyanins rich-food can accumulate in tissues, as suggested by Kalt et colleagues 2008 (33), low µM or high nM are certainly the more reasonable concentrations to test on brain cells.  Healthy neurons constitutively express high levels of the chemokine CX3CL1 (also known as fractalkine), whereas the corresponding receptor CX3CR1 is found in microglia.  The axis CX3CR1/CX3CL1 represents one of the most important axis between microglia and neurons (8). Impaired cognition was indeed observed in genetic knockout mice missing CX3CR1 (34). Contrary to what would be expected, the expression CX3CR1 on microglia cells was decreased by IL-4, either in the presence or absence of flavonoids, however absence of ligand regulation may be implicated.  Despite flavonoids did not significantly increase this receptor, Cy did increase its ligand release by neurons. Cy3glc effect appeared to differ from other compounds tested, increasing CX3CR1 mRNA expression either in basal and LPS-stimulated cells. The subsequent application of flavonoids directly to neuronal cells allow to test a direct effect on prevention of microglia CM effects. Results confirmed the ability of the anthocyanidin to modulate neuronal fractalkine expression as already reported (15), even in a pro-inflammatory environment.  Selective modulation of microglia polarization to M2 phenotype has been presented as possible therapeutic target for some pathological conditions (35). Also, modulation of microglia biology affects neurons biology and plasticity, which can be helpful to increase its functionality even in physiological conditions (36). Microglia biology and its influence on neuronal function is a field that is evolving and concepts have been changing. This work results showed an attenuation of M1 phenotype. The M1/M2 polarization is not a standardized categorization, and although flavonoids are indeed able to decrease some pro-inflammatory cytokines as TNF-α, a marked effect on inducing alternative cytokines release was not seen. Although the usefulness of the terms M1 and M2, microglia cells are plastic and can shift between a spectrum of phenotypes instead of just fit in one closed classification. Anthocyanins and metabolites were not able to shift microglia to an M2 strict phenotype however they do interact with microglia biology, and furthermore with neuron biology, by increasing CX3CL1 expression. These results help to dig into the 
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CONCLUDING REMARKS 
With the increase in life expectancy, chronic diseases that affect brain function have also 
increased. Nowadays people are currently exposed to demanding tasks and keeping a healthy 
brain, either to optimizing its function or delaying its complications typical of ageing, is crucial. 
Flavonoids, which have been extensively studied for their potential to treat cardiovascular 
diseases and cancer, have been attracting the interest of scientific community for its 
neuroprotective potential. The compilation of works presented in this thesis aimed to expand 
the understanding of the effects of flavonoids on brain function and to explore its therapeutic 
potential.  
A strong body of literature has shown the ability of flavonoids and other polyphenols to 
modulate several membrane transports at intestinal and placental barrier (Martel, Monteiro et 
al. 2010). Blood-brain barrier (BBB) is one of the tightest barriers in mammalians that regulate 
the access of a plurality of bioactive compounds to the brain. Ability of flavonoids to cross this 
barrier has already been shown (Youdim, Dobbie et al. 2003, Faria, Pestana et al. 2010, Faria, 
Meireles et al. 2014), however there was lack of knowledge about the effects they can have on 
membrane transport of other compounds at this level.  
Glucose is the main fuel to brain cells, which even in rest are able to consume 20% of energy 
necessary to meet our basal demands. To work properly, our brain needs, at first instance, 
energy. Paradoxically, brain has limited stores of glycogen (Owen and Sunram-Lea 2011) and it 
depends on a tight regulation of glucose to maintain its homeostasis. BBB can adapt the glucose 
transport in response to neuroglial signals to adjust to brain demands (Leybaert, De Bock et al. 
2007). However, this process is not always perfect - poor glucose regulation occurs and is 
associated with memory impairment and age-related cognitive deficits. Furthermore, previous 
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research has demonstrated that glucose administration can enhance learning and memory in 
healthy young and aged animals and humans and may even improve several cognitive functions 
in individuals with Alzheimer’s disease (Craft, Zallen et al. 1992, Messier, Gagnon et al. 1997) and 
Down’s syndrome (Manning, Honn et al. 1998) whose cognition is severely compromised. 
Furthermore, impairments in certain cognitive skills have been recognized as a possible 
complication of diabetes mellitus, and evidence exists that improved glycemic control can 
ameliorate performance on selective areas of cognition in these populations (Seto, Yang et al. 
2015). Glucose administration as enhancer of memory performance in healthy young adults has 
also been suggested (Sunram-Lea, Foster et al. 2001).  
In the present work we verified that flavonoids are important modulators of glucose levels 
also at BBB level in addition to modulation at other biological barriers as previously mentioned. 
Curiously, results showed that flavonoids belonging to two different structural classes have 
different effects on glucose modulation. The flavan-3-ols catechin and epicatechin did not have 
any effect on [3H]-DG uptake. However their methylated forms were able to increase this 
uptake. The effect with flavonols was in a different direction: both quercetin and miricetin 
decreased glucose uptake in a concentration-dependent manner. However, the glucuronic acid 
conjugated of quercetin, one of the most abundant circulating metabolites of quercetin after 
ingestion of a quercetin-rich meal (Mullen, Boitier et al. 2004), produced no effect on glucose 
uptake in BBB which could support a reduced impact of quercetin ingestion on glucose uptake. 
Indeed, metabolization can affect flavonoids action, which can be an indirect way for the 
organism to control and modify flavonoids action and restore homeostasis (Williamson 2013). 
 Some of the questions that could be raised after the results of the chapter II is whether 
glucose facilitation can have beneficial or detrimental effects. Taking in account that glucose 
effects are U inverted shaped, the answer for this question would depend on the requirement of 
brain for glucose, which is known to change according to the tasks demanded to the brain (van 
der Zwaluw, van de Rest et al. 2015). 
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Once brain energetic needs are accomplished, neurological functions are tightly dependent 
on the neurotransmitters released. Some of the most common neurological diseases are directly 
or indirectly related to problems with neurotransmitters. These neurotransmitters as well as 
other endogenous bioactive amines and vitamins are organic cations and depend on organic 
cation transporters systems (Koepsell, Lips et al. 2007).  
In chapter III we sought to explore whether flavonoids were able important transport 
systems also at neuronal level and by these way account for its neuroprotection potential. [3H]-
1-Methyl-4-phenylpyridinium ([3H]-MPP+) is a classic substrate for organic cation transporters 
and previous studies had already shown that MPP+ uptake was susceptible to flavonoids 
interference at intestinal levels. However, at neuronal level, the transporters involved are 
different and there were no information about flavonoids action there.  SH-SY5Y cell line is 
commonly used as model of dopaminergic neurons. After differentiation these cells acquire a 
dopaminergic phenotype, characterized by expression of enzyme tyrosine hydroxylase and 
dopamine transporter (DAT) (Presgraves, Ahmed et al. 2004). The DAT is responsible for 
recycling dopamine (DA) from the synaptic cleft and modulation at this level would for instance 
regulate levels of dopamine available for neurotransmission. Depression, bipolar disorder, 
Parkinson’s disease, and attention deficit hyperactivity disorder are associated with abnormal 
dopamine levels and DAT may be implicated in some of these conditions. Inhibitors or agonists 
of DAT are being considered as new approaches to treat these disorders (Vaughan and Foster 
2013).  
The results presented in this chapter showed a partial involvement of DAT on [3H]-MPP+, 
uptake, and therefore, a possible involvement of flavonoids on modulation of this transporter. 
Inhibition of [3H]-MPP+ uptake by flavan-3-ols can affect neurotransmission by increasing 
dopamine on the synaptic cleft. However, naringenin, hesperitin, quercetin and metabolites 
increased this uptake. This increase can be helpful in psychoses where synaptic cleft levels of 
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dopamine are increased as schizophrenia or situations of drugs abuse like methamphetamines 
and cocaine (Sekine, Iyo et al. 2001, Deik, Saunders-Pullman et al. 2012).  
Overall, this work showed that organic cations uptake in dopaminergic neurons may be 
modulated by diet flavonoids and most interesting, by its biological metabolites, in structural-
dependent way. This uptake seemed to be regulated by Ca2+ pathways, 
phosphorylation/dephosphorylation mechanisms and have a partial involvement of DAT. 
Interference of flavonoids with multiple signaling cascades has been review by Spencer et al.,  
2009 (Spencer 2009). This include selective actions on a number of protein kinases and lipid 
kinase signaling cascades, most notably the PI3K/Akt and MAP kinase pathways which regulate 
pro-survival transcription factors and gene expression. Inhibition of apoptosis triggered by 
neurotoxic species represents a way to maintain a good number of functional neurons. 
Notwithstanding, the potential to inhibit or stimulate important transport systems may change 
the communication between these cells which may be relevant to explain the potential 
neuroprotective actions of some flavonoids.  
Chapter II shows flavonoids’ ability to modulate glucose uptake at BBB which may explain 
some of beneficial actions previously seen with flavonoids. Although glucose is necessary for 
adequately brain function, an excess on plasmatic glucose levels as seen in diabetic patients is an 
established risk factor for cognitive impairment. On chapter III it was observed an ability of 
flavonoids to modulate organic cation uptake which may have impact on neurotransmitters 
availability and synapse function. The connection between these two approaches was made on 
chapter IV where was tested the long-term consumption effects of flavonoids in the 
dopaminergic system, in diet-induced obese rats, where hyperglycaemia was expected.  
There is a widespread concern regarding the effects of modern, typically westernized dietary 
patterns, characterized by high-fat and high-sugar foods. These diets have been mimicked in rats 
and used as model to induce obesity and the co-morbidities associated. In vivo studies have 
shown that high-fat diet fed animals have several brain disorders among them, dysfunction of 
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dopaminergic system and of neurogenesis impairment (Kanoski and Davidson 2011). Berries, 
natural source of flavonoids, have attracted interest as nutritional approach to improve health, 
metabolic and cognitive outcomes (Basu, Rhone et al. 2010, Rendeiro, Guerreiro et al. 2012, 
Norberto, Silva et al. 2013). Extract from blackberries was chosen due its natural high content on 
anthocyanins, characterized mainly by cyanidin-3-glucose. Also, previous studies had pointed 
blackberry extracts as improvers of cognitive function and antioxidant status in animal studies 
(Shukitt-Hale, Cheng et al. 2009, Hassimotto and Lajolo 2011).  
Previous studies have suggested an association between glucose and dopamine levels, with 
low levels of glucose in the brain inhibiting DA release. Animal supplementation with blackberry 
extract (BE) decreased dopamine content in striatum and increased DOPAC/DA ratio indicating a 
higher DA turnover with BE supplementation. Also, BE supplementation acted towards an insulin 
mimetic direction reinforcing the involvement with glucose systems. This study also confirmed 
that high-fat, high-carbohydrate diet induced obesity can prompt several features of metabolic 
dysfunction in Wistar rats, some of them being partially reverted with low doses of blackberry 
extract.  
Taking into account that neuroinflammation has been suggested as a central mediator of 
central nervous system (CNS) dysfunction (Yirmiya, Rimmerman et al. 2015), the following work 
(described in chapter V) aimed to assess the impact of a chronic blackberry anthocyanin extract 
supplementation on the neuroinflammatory profile using the in vivo design described on chapter 
IV. Results obtained in this study went further than showing the potential of anthocyanins to 
counteract diet-induced inflammation, but also suggested that, without an inflammatory 
context, anthocyanins are able to modulate processes involved in synaptic plasticity. PDGF-AA 
and fractalkine, as example, were consistently modulated by BE supplementation in the cortex 
and the hippocampus of standard fed animals. Moreover, the BE supplementation also 
increased cortex expression of activin A, agrin, and VEGF, all known to be important in synapse 
structure, regeneration and synaptogenesis (Shoji-Kasai, Ageta et al. 2007, Rosenstein, Krum et 
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al. 2010, Daniels 2012). The modulation of fractalkine expression by BE was one of the most 
consistent findings, since it was increased in both cortex and hippocampus of supplemented 
animals, independently of fat diet content.  Fractalkine is a chemokine synthetized by neurons, 
whose receptor is highly expressed in microglia cells (Kettenmann, Kirchhoff et al. 2013). 
Fractalkine (CX3CL1) and its receptor (CX3CR1) represent an important axis in 
neuronal/microglial crosstalk and modulation at this axis may be essential in maintaining 
microglia in a resting state in the healthy brain as well as preventing excessive microglial 
activation during inflammatory conditions (Jurgens and Johnson 2012, Wolf, Yona et al. 2013). 
Previous data suggested that flavonoids were capable of changing the phenotype of microglia by 
restoring the population of microglial cells to the “resting” state from the more active state (Jang 
and Johnson 2010).   
To further explore the ability of BE to modulate fractalkine expression, anthocyanins and 
their physiological metabolites were assessed in vitro for their potential to influence neuronal 
fractalkine mRNA expression. Cyanidin markedly increased the expression of fractalkine at the 
concentration of 1 µM, whilst cyanidin-3-glucoside and metabolites induced a significant 
reduction on fractalkine mRNA levels.  Despite the disparity between our in vitro and in vivo 
models, the in vitro data confirm the potential of flavonoid aglycones to affect fractalkine 
expression. Nevertheless, in vitro models lack the complexity of the CNS, notably here the 
absence of microglia and astrocytes which may be required for the optimal regulation of 
inflammatory proteins. The following work, described in chapter VI, took into account the 
dynamic microglia-neuron using conditioned medium of treated or untreated microglia to 
culture neurons for 24 hours. 
From the results of chapter V and the continuous literature being published about microglia 
phenotype and the new roles of microglia in brain, a new hypothesis was raised: are flavonoids 
able to change synaptic plasticity? And if so, are this changes dependent on microglia 
phenotype? Results from these work pointed the effects of synaptic plasticity as not so depend 
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on microglia phenotype as hypothesized. Anthocyanins and metabolites were not able to shift 
microglia to an M2 strict phenotype however they did interact with microglia biology, showing 
an attenuation of M1 phenotype, and furthermore with neuron biology, increasing CX3XL1 
expression. 
The works presented in chapter V and VI suggested an influence of flavonoids, specifically 
anthocyanins, in the stimulation of transcription and production of molecules involved in 
synaptic plasticity. One of the most remarkable capabilities of the brain it is its ability to respond 
and adapt accordingly to different stimulus. This brain plasticity is characterized by the ability to 
increase number of mature neurons from neural stem cells – neurogenesis – and by changing 
the connections between the existent ones – synaptic plasticity. Synaptic plasticity is closely 
associated to microglia function which has a determinant role in synaptic pruning. Diet is among 
the environmental factors that stimulates and impacts brain function either by changing synaptic 
plasticity or microglia function (Stangl and Thuret 2009, Johnson 2015) and here anthocyanins 
showed some impact on these processes either in vivo and in vitro models. 
Flavonoids and other polyphenols in general keep on the top list of promising dietary 
interventions to impact brain function along with caloric restriction, intermittent fasting, and 
poly-unsaturated fatty acids (PUFA) (Murphy, Dias et al. 2014). Caloric restriction has been 
extensively studied due to its “healthspan” potential including delaying the onset of age-related 
process, as cognitive decline. It appears to improve the resistance of synapses to metabolic and 
oxidative damage. Also the total number, structure, and functional status of synapses and 
induces the production of neurotrophic factors can be modulated by caloric restriction (Mattson 
2012). Dietary interventions that could mimic the effects of caloric restriction without the 
constraint of food intake has become an attractive field of research. On this regard, resveratrol, 
naturally occurring in grapes and wine, has attracted scientific community interest (Baur 2010). 
It could be interesting to establish if the structural close flavonoids are able to prevent cognitive 
decline also by acting on the same molecular targets as caloric restriction.  
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The future in flavonoid research will work on establishing a dietary recommendation intake 
for flavonoids and other bioactive compounds as has been recently discussed by a panel of 
experts. Although the challenge, establishing a reference intake value would help scientists to 
design convergent studies and lead science to a faster progress (Lupton, Atkinson et al. 2014). 
The habitual intake of flavonoids in Europe is below the amounts found to have a significant 
health effect (Vogiatzoglou, Mulligan et al. 2015).  It would be beneficial for consumers to set a 
goal for the amount needed to incorporate in diet (Williamson and Holst 2008). This is only 
possible after well designed randomized controlled trials with dose-efficacy and safety tests. 
Short-term clinical trials could focus on cognitive disorders whereas long-term trials could focus 
on prevention and treatment of neurodegenerative diseases and age-related brain dysfunction 
(Lupton, Atkinson et al. 2014, Balentine, Dwyer et al. 2015). A few years ago clinical trials on 
flavonoids and cognition were sparse (Macready, Kennedy et al. 2009). At the present several 
trials on cognition are ongoing and this knowledge will be continuously increased.  
The work presented in this thesis pointed flavonoids as modulators of metabolism, either in 
physiological conditions or by changing the response induced by high-fat diet (Figure 2). 
Modulation of glucose metabolism had a special relevance since flavonoids changed the access 
of glucose by CNS as well as presented insulin mimetic actions in vivo. Flavonoids had also 
impact on CNS parameters that may be directed or undirected related with metabolism. 
Flavonoids were able to modulate dopaminergic system, modify markers of classic activated 
microglia and counteract neuroinflammation induced by high-fat diet in vivo. Modulation of 
transporters and proteins involved in synaptic plasticity by flavonoids may be also relevant to 
restoring homeostasis in pathological conditions or could represent an improvement in 
physiological brain functions.  
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Figure 2-Schematic representation of the effects of flavonoids explored in this work. 
It was also clear that structural difference between flavonoids, natural or as result of 
metabolization can impact their biological activity. Chronic supplementation with an 
anthocyanin rich extract allowed us to explore some of the mechanisms proposed in vitro and to 
suggest new ones. This work presented some explanations which may help to determine and 
understand the biological efficacy of flavonoids. Moreover, the effects of flavonoids explored 
here can give important clues about which specific outcomes to measure and explore in future 
clinical trials. Given the high prevalence of dementia, even a small impact on delaying cognitive 
decline might have a serious impact on public health.  
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